ABSTRACT-In passively sensitized guinea pigs, slow infusion of an amount of ovalbumin insufficient to evoke airway obstruction induces hyperreactivity of the airways. A wide range of changed responsivity was observed for different test spasmogens, with leukotriene C4 > histamine > prostaglandin Fl, > bradykinin > leukotriene E4> serotonin > acetylcholine. Injection of ovalbumin as a bolus produced pronounced airway obstruction without hyperreactivity. Airway obstruction due to vascular engorgement (dextran infusion) or edema (histamine infusion) did not result in hyperreactivity. Infusion of PAF induced pronounced airway obstruction together with hyperreactivity, but with a rank order of histamine>leukotriene C4> serotonin > bradykinin > leukotriene E4 > acetylcholine. It can be concluded that allergic airway hyper reactivity in the guinea pig is spasmogen-selective and largely independent of airway obstruction. These observations question the presumption of non-selective hyperreactivity in allergic asthma and cast doubt upon the proposal that airway hyperreactivity is secondary to airway obstruction.
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Keywords: Bronchoconstriction, Hyperreactivity (airway), Platelet activating factor, Passive sensitization Sensitized guinea pigs respond to allergen with acute allergic bronchospasm that may be sufficiently intense to cause obstruction of airflow and death. It might be pre sumed that hyperreactivity to allergic mediators contrib utes to allergic bronchospasm; however, allergic hyper reactivity remains poorly defined in the guinea pig, even though this phenomenon is well documented for irritants (1) (2) (3) , drugs (4-7) and inflammatory mediators (8, 9) . Thus, no increased responsivity to acetylcholine or histamine was detected in actively sensitized guinea pigs (10) , yet hyperreactivity of the airways to inhaled hista mine was reported to follow anaphylactic microshock (11) .
Conflicting results may have arisen because of differing sensitization procedures, use of particular test spasmo gens, confounding effects of systemic hypotension, an oxia and persisting airway obstruction. The present study has defined conditions which allow reproducible induc tion of allergic airway hyperreactivity and has investigat ed the extent to which acute airway obstruction, mast cell activation, smooth muscle spasmogen characteristics and immunoglobulin category determine the intensity of acute airway hyperreactivity in this species. . Coinci dent pressure changes within the thorax were measured via an intrathoracic cannula, using a differential pressure transducer (MP 4524, Validyne), so that the pressure difference between the trachea and thorax could be meas ured and displayed. To monitor the physiological status of the animal during experimental investigations, the blood pressure and heart rate were recorded from the carotid artery by a pressure transducer (Isotec; Hugo Sachs, Freiburg, Germany); and a cannula was intro duced into the right jugular vein to allow intravenous infusion of agents that influence airway reactivity and into the left jugular vein, for administration of test spas mogens. To achieve a uniform rate of injection, test materials (e.g., spasmogen) were injected intravenously in a volume of 0.2 ml to occupy the dead space in the can nula. This was followed by saline (0.5 ml over 30 sec) at a constant rate (1 ml/min) from an infusion pump (Perfu sor IV; Bender & Hobein, Zurich, Switzerland). From measurements of air-flow and transpulmonary pressure, both RL and Cdyn were calculated after each respiratory cy cle using a digital electronic pulmonary monitoring sys tem (PMS; Mumed, London, UK) which displayed blood pressure, intrathoracic pressure and airflow and comput ed RL and Cdyn in real time for display on a visual display unit (Premium II 486/33; AST, Irvine, CA, USA). Ex perimental data were stored electronically, and experimen tal traces or processed data were plotted on a laser jet printer (Laser Jet Series II; Hewlett Packard, Palo Alto, CA, USA).
MATERIALS AND METHODS

Materials
Dextran (6%, 20 ml) or histamine (3 pg/kg/min, 4 ml) were infused intravenously over 30 min; PAF (600 ng/kg, 6.34 ml) was infused in three successive aliquots (30 ng/kg, 0.32 ml, 10 min; 120 ng/kg, 1.27 ml, 20 min; 450 ng/kg, 4.75 ml, 30 min); OA (32 pg/kg, 3 ml) was infused for 60 min or injected as a bolus (32 tcg/kg in 0.2 ml plus saline 0.5 ml) in animals that had been sensitized 1-14 days earlier by intravenous injection of 1.0 ml of serum collected from animals exposed to OA (10 tlg) admixed with Al(OH)3 (10 mg) and injected together with Bordetel la pertussis (0.25 ml) 21 and 7 days prior to collection of the blood and separation of the serum. Seven days after intradermal injection of antiserum, PCA reactions (mm diameter) (n=5) were: 15, 12, 6, 0 and 0 when the serum had been heated (561C for 4 hr) as compared with > 30, > 30, 25, 22 and 20 when the serum was not heated.
Intravenous injection of bolus doses of 5-HT (1.0-3.2 pg/kg), PGF2a (32-100 tcg/kg), ACh (3.2-18 pg/kg), histamine (0.56-1.8 ttg/kg), LTC4 (56-320 ng/kg) or LTE4 (180 560 ng/kg) at 10-min intervals or BK (0.32 3.2 pg/kg) at 30-min intervals, were used to ascer tain the sensitivity of airway smooth muscle. These proce dures were repeated 10 min after termination of an intra venous infusion of dextran, histamine or antigen or 20 min after intravenous infusion of PAF.
Data presentation and statistics
Responses to test spasmogens have been expressed as incremental increased resistance (dRL) and decremental decreased compliance (iCdyn), being the maximal change less the basal value prior to injection of spasmogen. Air way responsivity to intravenous spasmogens has been esti mated as the dose-effect slope for RL (cmH2O/l/sec) over a logo dose-metameter, using RS1 (BBN Software Product Coporation, Cambridge, MA, USA), which estimates the slope by least squares regression and indicates linearity by statistics. For the purpose of comparison, sensitivity has been expressed as an SR (dose-effect slope after treat ment/dose-effect slope before treatment). Statistical sig nificance of differences observed have been assessed by Student's t-test.
RESULTS
Airway obstruction following injection of ovalbumin
Animals that had been sensitized by intravenous injec tion of antiserum 1 day earlier responded to injection of OA (32,ug/kg, i.v.) with acute airway obstruction (dRL 467.5 ± 90.8 cmH2O/l/sec, 4Cdyn -0.54±0.05 ml/cmH2O). In animals that had been sensitized 7 days earlier, bo lus injection of OA (32 tcg/kg, i.v.) produced a similar decrease of dynamic compliance (4Cdyn -0.56--L0.06 ml/cmH2O), yet increased airway resistance (dRL 161.8:±: 47.0 cmH2O/l/sec) was significantly (P < 0.05) less than that in animals tested 1 day after sensitization. This marked difference implies that whereas mediator release to cause edema in the lung periphery might be similar in the two situations, the release or action of mediators in the large airway was substantially different at the two times. The latency (< 10% of maximum RL) and time to maximal response were similar in both groups of animals, but reac tions to OA were significantly (P <0.002) slower than sub sequent responses to histamine (1.8 rig/kg, i.v.) ( Table 1) .
Altered responsivity to histamine following infusion of OA In animals that had been sensitized 7 days earlier, responsivity to histamine (0.56-1.8,ug/kg, i.v.) was deter mined immediately before and 10 min after the infusion of OA (0-320 gig/kg for one hour). Incremental in creased responsivity to histamine was detected when the dose of OA exceeded 10 ppg/kg, but responsivity was not significantly increased (P<0.05) for doses less than 32 pg/kg (Fig. 1) . Variation of the interval between sensitiza tion and infusion of OA (32 ,ug/kg) revealed that sensitiv ity to histamine increased progressively, but was not sig nificantly increased (P < 0.05) earlier than 3 days after sen sitization (Fig. 2) . In animals passively sensitized 1 or 7 days earlier, intravenous injection of the same quantity of OA as a bolus evoked acute bronchospasm, without at tendant hyperreactivity to histamine (Table 1) . Table 1 . The latency to onset (< 10% of maximum response) and maximal response (RL) following intravenous injection of OA (32 pg/kg) or histamine (1.8 pg/kg) in naive animals and in animals passively sensitized 1 or 7 days prior to study 
Altered responsivity to different spasmogens following infusion of OA
In animals that had been sensitized 7 days earlier, infu sion of OA (32 pg/kg/hr) increased the sensitivity to hista mine (0.56-1.8 pg/kg), so that the slope (loglo dose metameter) of the dose-effect relationship increased from 144.0 cmH2O/l/sec to 455.5 cmH2O/l/sec, giving a slope ratio of 3.16 (n=10). Corresponding experiments with other spasmogens revealed a wide range of changed responsivity, with substantially increased responsivity for allergic spasmogens such as LTC4 (SR = 5.48, n=10), PGF2a (SR=3.11, n=10), BK (SR=2.70, n=10) and LTE4 (SR = 2.51, n =10), yet little change in responsivity to 5-HT (SR=1.31, n=10) or ACh (SR=1.13, n=10) ( Table 2 ). Compliance changes following infusion of OA (32 pg/kg/hr) were small and inconsistent (Table 3) , and dose-related compliance changes to injected spasmogens after infusion of OA were only detected using PGF2a or 5-HT.
Airway obstruction and airway hyperreactivity
In anesthetized ventilated guinea pigs, infusion of dex tran (40 ml/hr) causes vascular engorgement and hence physical occlusion of the airways. By 30 min, airway resistance and dynamic compliance had changed substan tially (Table 3 ), yet sensitivity to histamine (SR =1.21, n=10) was similar to that observed following infusion of saline (SR=1.50, n=10). Intravenous infusion of hista mine (3 tcg/kg/min) over 30 min produced edema of the airways with substantial and maintained increased airway resistance and decreased dynamic compliance (Table 3) . Nonetheless, airway responsivity to ACh (SR=0.88, n= 10) was less than that in animals exposed to an infu sion of saline (SR=1.23, n=10). For LTC4 there was reduced responsivity (SR=0.64, n=10), but this was not as marked as the reduction following the infusion of sa line (SR=0.19, n=10) .
In clinical asthma, changed responsivity following IgE mediated reactions has been attributed to the release of al lergic mediators; however, of the known allergic media tors, only PAF has been shown to effect sustained airway hyperreactivity in the guinea pig under the test conditions employed. Intravenous infusion of PAF caused increased airway resistance and decreased dynamic compliance (Table 3) , with increased responsivity to histamine (SR=2.67, n=10), LTC4 (SR=2.53, n=10), 5-HT (SR = 2.15, n=10) and, to a lesser extent, bradykinin (SR =1.45, n=10) and LTE4 (SR =1.20, n=10), while responsivity to ACh (SR=0.87, n=10) was diminished (Table 4) . No dose-related decremental decrease of dynam ic compliance was observed for any of the spasmogens tested. Table 2 . Mean incremental increased RL in response to intravenous injection of airway spasmogens at three dose levels, before (RL pre) and after (RL post) intravenous infusion of OA (32 pg/kg) over 1 hr (n=10 in each instance) Table 3 .
Effects of treatments on basal RL and Cdr,,, Table 4 . Mean incremental increased RL in response to intravenous injection of airway spasmogens at three dose levels, before (RL pre) and after (RL post) intravenous infusion of PAF (600 ng/kg) over 1 hr (n = 10 in each instance)
IgE and allergic hyperreactivity The method used for generation of antiserum in this study has been reported to evoke IgE formation in this species (12) . To ascertain whether IgE-mediated responses contributed to acute allergic bronchospasm or allergic hyperreactivity, serum was heated for 4 hr at 56'C, prior to intravenous injection. Animals that received heated serum 7 days before injection of OA (32 pg/kg/hr) had significantly (P<0.05) smaller responses to histamine (1.8 ug/kg) than had been observed in animals receiving unheated serum (Fig. 3) . 
DISCUSSION
The present study has confirmed that acute allergic bronchospasm in the guinea pig is not necessarily associat ed with airway hyperreactivity (10) and that minimal aller gic reactions are associated with expression of airway hyperreactivity (11) . The inability of acute allergic bron chospasm to lead to expression of airway hyperreactivity cannot be attributed to suppression of airway responses by endogenous hormones (such as adrenaline or glucocor ticosteroids), since there was no impairment of responsiv ity to histamine in these animals; moreover, comparable acute airway obstruction following infusion of PAF was accompanied by unequivocal airway hyperreactivity. It follows that neither sensitization per se nor activation of mast cells to produce acute allergic bronchospasm pro vide a basis for airway hyperreactivity in this species.
Sensitization over several days and slow infusion of OA consistently induced increased responsivity to histamine. Slow infusions of OA, 1 day after sensitization, did not lead to changed responsivity to histamine, even though such animals exhibited more intense reactions to injection of OA as a bolus than did animals tested 7 days after sen sitization. These observations imply that the process of passive sensitization is accompanied by a parallel event which modifies the response to antigen in sensitized cells. Processes such as receptor cross-talk between IgG and IgE molecules during interaction with antigen which might account for this phenomenon have yet to be investi gated. Whatever mechanism accounts for this prolonged latency, it is not peculiar to IgE.
It is widely accepted that non-selective airway hyper reactivity might be expected when airways narrow (13, 14) . In the present study, substantial airway obstruction has been effected by vessel engorgement following intra venous infusion of dextran and by edema due to intra venous infusion of histamine. In neither instance was noteworthy increased responsivity of the airways detect ed. The implied lack of association between airway responsivity and airway obstruction was strongly rein forced by investigation of the allergic reaction. Thus, in jection of antigen as a bolus evoked airway obstruction without changed responsivity to histamine, whereas injec tion of the same dose of antigen by slow infusion in creased responsivity to histamine in the absence of airway obstruction, albeit only when recipient animals had been sensitized several days earlier.
An alternative test of the concept that airway obstruc tion determines airway hyperreactivity was to investigate the presumption that hyperreactivity of the airways is non-selective. By extending the range of test spasmogens, it was evident that manifestation of hyperreactivity was determined by the test spasmogen. For allergic hyper reactivity, these differences were not slight; and in com parison with the infusion of saline, exposure to antigen yielded changes of responsivity that ranged between less than 10076 and more than 2500%. The rank order of spas mogen responsivity following an allergic reaction may provide a more stringent criterion (15) for identification of autacoids as mediators of allergic hyperreactivity. For instance, the present study revealed that infusion of PAF led to hyporeactivity if acetylcholine was the test spas mogen and showed that in comparison with antigen, there was less intense airway hyperreactivity to all other test spasmogens, with the exception of serotonin. Hence, the rank order of spasmogen sensitivity after infusion of PAF was distinct from that observed following an allergic reaction.
It can be concluded that in the anesthetized ventilated guinea pig, increased responsivity to airway spasmogens is a selective process. Heterogeneity of airway hyper reactivity cannot be a direct consequence of airway obst ruction, being evident in animals that show profound air way obstruction (as following infusion of PAF) and in animals that exhibited no overt airway obstruction (as following an infusion of antigen). In these circumstances, it is possible that vagal reflexes contribute to increased responsivity of the airways, since airway hyperreactivity due to infusion of (±)isoprenaline (5), ozone (2), antigen (16), immune complex deposition or infusion of neuro peptides (J. Morley et al., unpublished observations) are pre-empted or diminished by bilateral vagal section. No subcellular mechanism has been defined to account for in creased airway responsivity in the guinea pig; however, in tracellular recording from bronchial neurons has revealed membrane depolarization and enhanced excitability of these cells following exposure to antigen (17), a phenomenon which could account for the differential in creased responsivity of airway smooth muscles to spasmo
gens. This study has demonstrated that expression of an acute allergic reaction was insufficient to account for air way hyperreactivity in the guinea pig, which is consistent with the clinical finding that suppression of acute manifestations of the allergic response is not necessarily accompanied by diminished hyperreactivity (18, 19) and the lack of clinical efficacy of compounds selected as anti asthma drugs by reference to acute allergic reactions (20) . Observation of changed responsivity to inhaled spasmo gens following inhalation of allergen is a widely used tech nique for studying the airway hyperreactivity in clinical asthma. Heterogeneity of airway hyperreactivity in this situation is not yet established, but seems likely since sub stantial (20 to 30-fold) and protracted (2-4 weeks) in creased responsivity to bradykinin cannot be accommo dated with the coincidental slight (2 to 3-fold) and tran sient (1-2 days) changed responsivity to methacholine that follows inhalation of allergen (21) . Hence, use of histamine or methacholine sensitivity could be misleading when surveying sensitivity of the airways or sensitivity of airway hyperreactivity to therapeutic agents (22, 23) . It is to be hoped that these animal studies will prompt a defini tion of the pattern of airway reactivity to different spasmo gens in allergic asthma, since such observations may al low identification of a pivotal mediator of this phenom enon.
